UniProt P01889
HLA class I histocompatibility antigen, B-7 alpha chain (P01889)
HLA class I histocompatibility antigen, B-7 alpha chain (UniProt P01889): 38 experimental structures on GenesisL1, 8 ligands bound, 87 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P01889
- Protein
- HLA class I histocompatibility antigen, B-7 alpha chain
- Experimental structures
- 38
- Predicted models
- 0
- Ligands
- 8
- Pockets
- 87 · 12 records with a druggable one
Structures
38 records of P01889 in the MolNFT archive: 38 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 3VCL | Crystal Structure of HLA-B7 with the HCMV pp65 peptide RPHERNGFTVL | x-ray diffraction | A | — | — |
| 3VCL | Crystal structure of HLA-B7 with the hcmv PP65 peptide rpherngftvl | x-ray diffraction | A | — | — |
| 4U1H | HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1… | x-ray diffraction | A | — | — |
| 4U1H | HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1… | x-ray diffraction | A | — | — |
| 4U1K | HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1… | x-ray diffraction | A, D | — | — |
| 4U1K | HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1… | x-ray diffraction | A, D | — | — |
| 5EO0 | Crystal Structure of HLA-B0702-RFL9 | x-ray diffraction | A | — | — |
| 5EO0 | Crystal structure of HLA-B0702-RFL9 | x-ray diffraction | A | — | — |
| 5EO1 | Crystal Structure of HLA-B0702-RL9 | x-ray diffraction | A | — | — |
| 5EO1 | Crystal structure of HLA-B0702-RL9 | x-ray diffraction | A | — | — |
| 5WMN | Crystal structure of HLA-B7 in complex with spi, an influenza peptide | x-ray diffraction | A, C | — | — |
| 5WMO | Crystal Structure of HLA-B7 in complex with RPP, an EBV peptide | x-ray diffraction | A | — | 5 (best 0.68) |
| 5WMO | Crystal structure of HLA-B7 in complex with rpp, an EBV peptide | x-ray diffraction | A | — | — |
| 5WMP | Crystal structure of HLA-B7 in complex with tpr, a CMV peptide | x-ray diffraction | A | IOD, NA, CL, ZN | — |
| 6AT5 | Crystal structure of HLA-B*07:02 in complex with an ny-eso-1 peptide | x-ray diffraction | A | — | — |
| 6AVF | Crystal structure of the KFJ5 TCR-NY-ESO-1-HLA-B*07:02 complex | x-ray diffraction | H | — | 6 (best 0.72) |
| 6AVF | Crystal structure of the KFJ5 TCR-ny-eso-1-HLA-B*07:02 complex | x-ray diffraction | H | — | — |
| 6AVG | Crystal structure of the KFJ37 TCR-NY-ESO-1-HLA-B*07:02 complex | x-ray diffraction | G, F | — | 18 (best 0.77) |
| 6AVG | Crystal structure of the KFJ37 TCR-ny-eso-1-HLA-B*07:02 complex | x-ray diffraction | G, F | — | — |
| 6UJ7 | Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide | x-ray diffraction | A, D | K, NA, SO4 | 9 (best 0.80) |
| 6UJ7 | Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide | x-ray diffraction | A, D | K, NA, SO4 | — |
| 6UJ8 | Crystal structure of HLA-B*07:02 with wild-type IDH2 peptide | x-ray diffraction | A, D | SO4 | — |
| 6UJ9 | Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide in complex with Fab | x-ray diffraction | A | SO4 | 4 (best 0.69) |
| 6UJ9 | Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide in complex with Fab | x-ray diffraction | A | SO4 | — |
| 6VMX | Structure of HD14 TCR in complex with HLA-B7 presenting an EBV epitope | x-ray diffraction | A, F | — | — |
| 7LFZ | Human leukocyte antigen B*07:02 in complex with SARS-CoV2 epitope IPRRNVATL | x-ray diffraction | A | — | 5 (best 0.68) |
| 7LFZ | Human leukocyte antigen B*07:02 in complex with SARS-COV2 epitope iprrnvatl | x-ray diffraction | A | — | — |
| 7LG0 | Human leukocyte antigen B*07:02 in complex with SARS-CoV2 epitope SPRWYFYYL | x-ray diffraction | A | — | 4 (best 0.69) |
| 7LG0 | Human leukocyte antigen B*07:02 in complex with SARS-COV2 epitope sprwyfyyl | x-ray diffraction | A | — | — |
| 7LGD | HLA-B*07:02 in complex with SARS-CoV-2 nucleocapsid peptide N105-113 | x-ray diffraction | A, C | CL, SO4 | — |
| 7LGD | HLA-B*07:02 in complex with SARS-cov-2 nucleocapsid peptide N105-113 | x-ray diffraction | A, C | CL, SO4 | — |
| 7LGT | HLA-B*07:02 in complex with 229E-derived coronavirus nucleocapsid peptide N75-83 | x-ray diffraction | A, C | ZN, NA, CL, K | — |
| 7RZJ | Crystal structure of HLA-B*07:02 in complex with MLL(747-755) phosphopeptide | x-ray diffraction | A | GLC, FRU | 4 (best 0.68) |
| 7S79 | Structure of HLA-B*07:02 in complex with synthetic phosphono-mll peptide analog | x-ray diffraction | A | — | 5 (best 0.67) |
| 7S7D | Structure of HLA-B*07:02 in complex with synthetic sulfo-mll peptide analog | x-ray diffraction | A | — | 5 (best 0.68) |
| 7S7E | Structure of HLA-B*07:02 in complex with DOT1L(998-1006) peptide | x-ray diffraction | A | GLC, FRU | 2 (best 0.68) |
| 8TUB | HLA B7:02 with HPNGYKSLSTL | x-ray diffraction | F, C, G, J | — | 20 (best 0.84) |
| P01889 | AlphaFold monomer V2.0 prediction for HLA class I histocompatibility antigen, B alpha chain (P01889) | — | — | — |
Ligands
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.